Complementary approaches to assessing risk factors for interval breast cancer
- First Online:
- 176 Downloads
To examine risk factors for interval breast cancer among women screened in a population-based mammography program.
Risk for interval cancer was assessed in terms of both the incidence per 10,000 negative screens and the proportion of all breast cancers diagnosed among screened women. Interval (N = 557) and screen-detected cancers (N = 1,545) were identified among 208,667 women receiving mammography in Colorado (1994–2001). Logistic regression was used to assess independent effects of multiple factors.
Overall risk of interval cancer was 29.5/10,000 women screened. Incidence was higher in women >50 years (OR: 2.28, 1.86–2.80), with family history (OR: 2.23, 1.85–2.70), with dense breasts (OR: 3.84, 2.76–5.35), and using hormones (OR: 1.54, 1.20–1.97). Hispanics had lower incidence than Whites (OR: 0.52, 0.34–0.81). Interval cancers represented 26% of all cancers diagnosed. This proportion was higher in women <50 (OR: 1.41, 1.09–1.82) and in women with dense breasts (OR: 2.95, 1.94–4.48).
Incidence of interval cancer increases with age, breast density, hormone use, and family history. Attempts to reduce occurrence of these cancers through more sensitive and/or intensive screening should focus on these subgroups. The disproportionate number of interval cancers associated with young age and dense breasts suggests these cancers result from both rapid growth and difficulties in detection.
KeywordsInterval breast cancer Risk factor Ethnicity Family history
- 15.Nixon RM, Pharoah P, Tabar L et al (1999) Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial. Rev Epidemiol Sante Publique 48:325–333Google Scholar
- 18.Surveillance, Epidemiology and End Results (SEER) (2004). National Cancer Institute, U.S. National Institutes of HealthGoogle Scholar
- 26.U.S. Census Bureau, Population Division, 2002Google Scholar
- 30.Kavanaugh A, Byrnes GB, Nickson C et al (2008) Using mammographic density to improve breast cancer outcomes. CEBP 17(10):2818–2824Google Scholar
- 43.Guo YP, Martin LJ, Janna W, Banerjee D (2001) Growth factors and stromal matrix proteins associated with mammographic densities. CEBP 10:243–248Google Scholar
- 49.Klemi PJ, Toikkanen S, Rasanen O, Parvinen I, Joensuu H (1997) Mammography screening interval and the frequency of interval cancers in a population-based screening. Br Jr Cancer 75(5):762–766Google Scholar